Application of tDCS Stimulation in Controlling Refractory Status Epilepticus
ConditionRefractory Status Epilepticus
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age14-80
SponsorXuanwu Hospital, Beijing
About this trial
The purpose of the study is to assess the efficacy and safety of targeting tDCS stimulation for treatment of Refractory status epilepticus
Eligibility criteria
Qualifiers
Age between 14 and 80 year-old with Gender unlimited,
Suitable for EEG monitoring;
Clinical diagnosis of Refractory status epilepticus (status epilepticus that cannot be controlled by two types of antiepileptic drugs and at least one anesthetic);
Informed consent to participate in this study was obtained from the participants or their surrogates
Disqualifiers
Unstable vital signs (systolic blood pressure<90mmHg, heart rate<60 beats/min, pulse oxygen saturation<90%);
Having severe skull injury/defect or medical equipment implanted in the head;
Pregnancy;
With any implantable electronic instrument (including pacemakers, vagus nerve stimulators) or metal implanted devices.
Trial design
Treatments tested in this trial
- tDCS stimulation
- TDCS sham-stimulation
Treatment groups
32 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov